Printer Friendly

ACUSON REPORTS 2ND QUARTER 1993 RESULTS

 MOUNTAIN VIEW, Calif., July 28 /PRNewswire/ -- Acuson Corp. (NYSE: ACN), a leading manufacturer and international marketer of premium quality medical diagnostic ultrasound systems, today announced the results for the second quarter ended July 3, 1993.
 Sales for the second quarter were $72,100,000, compared to $87,715,000 reported in the prior-year period. The company incurred a one-time after-tax charge of 27 cents per share ($12,000,000 pre-tax) during the quarter to provide for costs associated with the restructuring of operations announced on June 2, 1993. Acuson second quarter earnings before inclusion of the restructuring charge were $1,078,000 or 4 cents per share. Including the restructuring charge, the company reported a net loss for the quarter of $6,722,000 or 23 cents per share. In the second quarter of 1992, the company reported net income of $11,021,000 or 31 cents per share.
 For the six months ended July 3, 1993, sales were $154,395,000, compared to $174,733,000 in the first six months of 1992. Net loss for the current six months, including the restructuring charge, was $1,707,000 compared to net income of $23,789,000 for the comparable 1992 period. Loss per share for the current six months, including 27 cents for restructuring, was 6 cents compared to net earnings of 66 cents per share in the year-earlier, six-month period.
 The company's restructuring of operations resulted in a reduction of about 15 percent of its worldwide work force, or approximately 250 employees. "This restructuring action was taken to adjust to the current weak world market demand for medical ultrasound products," said Samuel H. Maslak, Sc.D., president and chief executive officer for Acuson.
 "During the second quarter, Acuson announced new products with the features and value our customers need to compete successfully in this uncertain market environment," said Maslak. "We are gratified with the enthusiastic worldwide response by physicians to the introduction of Acoustic Response Technology (ART), the latest innovation to flow from our research and development programs."
 In 1992, the board of directors authorized the repurchase of up to 8,000,000 shares of Acuson common stock over an unspecified period of time. As of July 3, the company had repurchased 7,373,500 shares, and there were 28,678,125 shares of Acuson common stock outstanding.
 Acuson, with headquarters in Mountain View, had 1992 sales of $343 million.
 ACUSON CORP.
 Condensed Consolidated Statements of Operations
 (Unaudited, in thousands, except per-share amounts)
 Three Months Ended Six Months Ended
 July 3, June 27, July 3, June 27,
 1993 1992 1993 1992
 Net sales $ 72,100 $ 87,715 $154,395 $174,733
 Cost of sales 30,004 35,272 64,486 70,251
 Gross profit 42,096 52,443 89,909 104,482
 Operating expenses:
 Selling, general and
 administrative 26,422 26,058 53,460 50,123
 Product development 15,162 11,208 29,385 20,991
 Restructuring
 expense 12,000 --- 12,000 ---
 Total operating
 expenses 53,584 37,266 94,845 71,114
 Income (loss) from
 operations (11,488) 15,177 (4,936) 33,368
 Interest income, net 1,146 2,318 2,310 4,394
 Income (loss) before
 provision for
 (benefit from)
 income taxes (10,342) 17,495 (2,626) 37,762
 Provision for (benefit
 from) income taxes (3,620) 6,474 (919) 13,973
 Net income (loss) $ (6,722) $ 11,021 $ (1,707) $ 23,789
 Earnings (loss)
 per share $ (0.23) $ 0.31 $ (0.06) $ 0.66
 Weighted average common
 and common equivalent
 shares outstanding 28,991 35,287 29,293 35,897
 Condensed Consolidated Balance Sheets
 (In thousands)
 July 3, Dec. 31,
 1993 1992
 (Unaudited)
 ASSETS
 Current Assets
 Cash & short-term investments $ 55,023 $ 65,447
 Accounts receivable 63,509 73,969
 Inventories 41,283 43,503
 Prepaid expenses and other 32,057 26,220
 Total current assets 191,872 209,139
 Property and Equipment
 At cost net of accumulated
 depreciation and amortization
 of $67,219 in 1993 and
 $59,053 in 1992 48,236 50,813
 Other Assets
 Net investment in leases 19,737 15,375
 Other long-term assets 4,574 3,230
 Total assets $264,419 $278,557
 LIABILITIES AND STOCKHOLDERS' EQUITY
 Current Liabilities
 Accounts payable $ 17,689 $ 13,829
 Accrued liabilities 62,799 63,582
 Total current liabilities 80,488 77,411
 Stockholder's Equity
 Common Stock
 Authorized - 50,000 shares
 Outstanding - 28,678 shares
 in 1993 and 29,818 shares
 in 1992 68,574 68,816
 Cumulative translation
 adjustment (1,754) (1,481)
 Retained earnings 117,111 133,811
 Total stockholders' equity 183,931 201,146
 Total liabilities and
 stockholders' equity $264,419 $278,557
 -0- 7/28/93
 /CONTACT: David L. Ringler of Acuson, 415-694-5303/
 (ACN)


CO: Acuson Corp. ST: California IN: MTC SU: ERN

GT -- SJ003 -- 6568 07/28/93 08:00 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 28, 1993
Words:802
Previous Article:AIRGAS, INC. REPORTS 67 PERCENT INCREASE IN EARNINGS IN FIRST QUARTER
Next Article:ACER GROUP POSTS STRONG FIRST-HALF GROWTH; MODULAR ASSEMBLY, NOTEBOOK SALES AND DRAM PROFITS BRING SOLID RESULTS
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters